Calidi Biotherapeutics
CLDI
CLDI
35 hedge funds and large institutions have $656K invested in Calidi Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
79% less capital invested
Capital invested by funds: $3.09M → $656K (-$2.44M)
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$16.4K | |
| 2 | +$10.3K | |
| 3 | +$10K | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$7.15K |
| 5 |
Goldman Sachs
New York
|
+$3.04K |
Top Sellers
| 1 | -$582K | |
| 2 | -$31.3K | |
| 3 | -$18.5K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$15.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$11.5K |
